FDA Puts Immucor On Notice For Safety Violations
FDA Enforcement Director David K. Elder sent Immucor a formal warning letter on May 2.
The document, which the FDA made public Tuesday, outlines several alleged violations of the Food, Drug & Cosmetic Act and gives Immucor 15 business days either to resolve them or to explain in writing why it needs more time.
“Failure to promptly...
To view the full article, register now.